enVVeno Medical Corporation
NASDAQ:NVNO
5.75 (USD) • At close July 26, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0.031 | 0.187 | 0.422 | 0.786 | 0 |
| Cost of Revenue
| 0.546 | 0.525 | 0.453 | 0.384 | 0 | 0 | 0.42 | 0.81 | 0 |
| Gross Profit
| -0.546 | -0.525 | -0.453 | -0.384 | 0.031 | 0.187 | 0.002 | -0.024 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 1 | 1 | 0.006 | -0.031 | 0 |
| Reseach & Development Expenses
| 13.583 | 9.914 | 5.728 | 4.252 | 2.206 | 1.239 | 0.65 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 11.109 | 15.018 | 11.165 | 4.883 | 4.912 | 6.483 | 5.456 | 4.635 | 1.29 |
| Other Expenses
| 0 | 0 | 0.033 | -0.216 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 24.692 | 24.932 | 16.893 | 9.135 | 7.118 | 7.722 | 6.106 | 4.635 | 1.29 |
| Operating Income
| -25.238 | -24.932 | -16.893 | -9.135 | -7.675 | -7.855 | -6.103 | -4.659 | -1.29 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | -245.665 | -42.105 | -14.459 | -5.928 | 0 |
| Total Other Income Expenses Net
| 1.722 | 0.263 | 0.365 | -0 | 0.05 | 1.353 | 0.231 | -0.871 | 0 |
| Income Before Tax
| -23.516 | -24.669 | -16.528 | -9.135 | -7.625 | -13.043 | -7.791 | -5.588 | -1.378 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | -244.067 | -69.915 | -18.458 | -7.111 | 0 |
| Income Tax Expense
| 0 | -0.365 | -0.331 | -0.216 | 0 | 1.673 | 0.21 | -2.143 | 0.314 |
| Net Income
| -23.516 | -24.304 | -16.196 | -8.92 | -7.625 | -13.043 | -7.791 | -3.387 | -1.604 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | -244.067 | -69.915 | -18.458 | -4.31 | 0 |
| EPS
| -1.91 | -2.16 | -1.87 | -6.91 | -12.1 | -34.83 | -20.1 | -7.72 | -3.66 |
| EPS Diluted
| -1.91 | -2.16 | -1.87 | -6.91 | -12.1 | -34.83 | -20.1 | -7.72 | -3.66 |
| EBITDA
| -24.692 | -24.509 | -16.752 | -8.963 | -6.64 | -7.402 | -7.674 | -4.508 | -1.164 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | -212.525 | -39.677 | -18.18 | -5.736 | 0 |